Novartis Stock Options Expiring on 16th of January 2026

NVS Stock  USD 99.17  0.96  0.96%   
Novartis' latest option contracts expiring on 2026-01-16 are carrying combined implied volatility of 0.17 with a put-to-call open interest ratio of 1.63 over 47 outstanding agreements suggesting investors are buying way more puts than calls on contracts expiring on 2026-01-16. The total put volume is at 270, with calls trading at the volume of 270. This yields a 2.11 put-to-call volume ratio.

Open Interest Against 2026-01-16 Option Contracts

Novartis option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Novartis' lending market. For example, when Novartis' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Novartis, he or she must hedge the risk by shorting Novartis stock over its option's life.
The chart above shows Novartis' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Novartis' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Novartis' option, there is no secondary market available for investors to trade.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novartis AG ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

Novartis AG ADR In The Money Call Balance

When Novartis' strike price is surpassing the current stock price, the option contract against Novartis AG ADR stock is said to be in the money. When it comes to buying Novartis' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Novartis AG ADR are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Novartis Current Options Market Mood

Novartis' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Novartis Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Novartis' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Novartis' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Novartis contract

Base on the Rule 16, the options market is currently suggesting that Novartis AG ADR will have an average daily up or down price movement of about 0.0106% per day over the life of the 2026-01-16 option contract. With Novartis trading at USD 99.17, that is roughly USD 0.0105. If you think that the market is fully incorporating Novartis' daily price movement you should consider buying Novartis AG ADR options at the current volatility level of 0.17%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  

Novartis Option Chain

When Novartis' strike price is surpassing the current stock price, the option contract against Novartis AG ADR stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Novartis' option chain is a display of a range of information that helps investors for ways to trade options on Novartis. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Novartis. It also shows strike prices and maturity days for a Novartis against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntExpirationCurrent SpreadLast Price
Call
NVS Option Call 16-01-2026 4702026-01-1670.0 - 75.064.0In
Call
NVS Option Call 16-01-2026 5002026-01-1654.0 - 59.061.5In
Call
NVS Option Call 16-01-2026 6002026-01-1639.0 - 44.048.0In
Call
NVS Option Call 16-01-2026 70242026-01-160.0 - 0.035.4In
Call
NVS Option Call 16-01-2026 80232026-01-160.0 - 0.025.0In
Call
NVS Option Call 16-01-2026 8542026-01-1626.5 - 31.532.08In
Call
NVS Option Call 16-01-2026 87532026-01-1621.5 - 26.520.94In
Call
NVS Option Call 16-01-2026 90112026-01-1615.9 - 17.616.5In
Call
NVS Option Call 16-01-2026 95172026-01-160.0 - 0.014.9In
Call
NVS Option Call 16-01-2026 97252026-01-160.0 - 0.013.33In
Call
NVS Option Call 16-01-2026 1003502026-01-160.0 - 0.09.7Out
Call
NVS Option Call 16-01-2026 1052032026-01-160.0 - 0.07.2Out
Call
NVS Option Call 16-01-2026 1102692026-01-160.0 - 0.04.66Out
Call
NVS Option Call 16-01-2026 1153062026-01-160.0 - 0.04.5Out
Call
NVS Option Call 16-01-2026 1203332026-01-160.0 - 0.02.4Out
Call
NVS Option Call 16-01-2026 1253912026-01-160.0 - 0.01.6Out
Call
NVS Option Call 16-01-2026 130702026-01-160.0 - 0.01.6Out
Call
NVS Option Call 16-01-2026 1353392026-01-160.0 - 0.01.25Out
Call
NVS Option Call 16-01-2026 140862026-01-160.6 - 0.81.15Out
Call
NVS Option Call 16-01-2026 145582026-01-160.0 - 0.751.4Out
Call
NVS Option Call 16-01-2026 15002026-01-160.45 - 0.61.09Out
Call
NVS Option Call 16-01-2026 15502026-01-160.6 - 0.851.4Out
Call
NVS Option Call 16-01-2026 16072026-01-160.15 - 0.40.3Out
Call
NVS Option Call 16-01-2026 1654292026-01-160.0 - 0.40.8Out
Call
NVS Option Call 16-01-2026 1703902026-01-160.15 - 0.350.55Out
Call
NVS Option Call 16-01-2026 175152026-01-160.0 - 0.00.1Out
 Put
NVS Option Put 16-01-2026 47292026-01-160.0 - 0.80.4Out
 Put
NVS Option Put 16-01-2026 552052026-01-160.3 - 0.50.33Out
 Put
NVS Option Put 16-01-2026 65252026-01-160.0 - 0.00.46Out
 Put
NVS Option Put 16-01-2026 701452026-01-160.5 - 2.30.5Out
 Put
NVS Option Put 16-01-2026 752382026-01-160.0 - 0.00.9Out
 Put
NVS Option Put 16-01-2026 8011492026-01-160.0 - 0.01.2Out
 Put
NVS Option Put 16-01-2026 855932026-01-160.0 - 0.01.65Out
 Put
NVS Option Put 16-01-2026 875682026-01-160.0 - 0.02.38Out
 Put
NVS Option Put 16-01-2026 906392026-01-160.0 - 0.03.25Out
 Put
NVS Option Put 16-01-2026 922952026-01-160.0 - 0.03.95Out
 Put
NVS Option Put 16-01-2026 953062026-01-160.0 - 0.04.71Out
 Put
NVS Option Put 16-01-2026 972482026-01-160.0 - 0.04.2Out
 Put
NVS Option Put 16-01-2026 1004212026-01-160.0 - 0.06.73In
 Put
NVS Option Put 16-01-2026 1053972026-01-169.3 - 9.66.6In
 Put
NVS Option Put 16-01-2026 11032026-01-168.5 - 13.55.9In
 Put
NVS Option Put 16-01-2026 115132026-01-160.0 - 0.014.05In
 Put
NVS Option Put 16-01-2026 120912026-01-1619.4 - 20.014.7In
 Put
NVS Option Put 16-01-2026 125102026-01-168.7 - 13.515.81In
 Put
NVS Option Put 16-01-2026 130522026-01-1623.5 - 28.021.08In
 Put
NVS Option Put 16-01-2026 135132026-01-1629.0 - 34.022.68In
 Put
NVS Option Put 16-01-2026 1401202026-01-1632.5 - 38.030.4In

Novartis Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

Novartis Market Cap Over Time

   Market Cap   
       Timeline  

Novartis Total Stockholder Equity

Total Stockholder Equity

57.16 Billion

At this time, Novartis' Total Stockholder Equity is comparatively stable compared to the past year.

Novartis Corporate Directors

Ton BuechnerNon-Executive Independent DirectorProfile
Frans HoutenNon-Executive Independent DirectorProfile
Nancy AndrewsNon-Executive Independent DirectorProfile
Elizabeth DohertyNon-Executive Independent DirectorProfile

Additional Tools for Novartis Stock Analysis

When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.